New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
04:55 EDTTLOG, TLOG, TLOG, TLOG, TLOG, AG, AG, AG, AG, AG, FMI, FMI, FMI, FMI, FMI, NLNK, NLNK, NLNK, NLNK, NLNK, TSRO, TSRO, TSRO, TSRO, TSRO, FPRX, FPRX, FPRX, FPRX, FPRX, SNSS, SNSS, SNSS, SNSS, SNSS, TROV, TROV, TROV, TROV, TROV, AZN, AZN, AZN, AZN, AZN, MRK, MRK, MRK, MRK, MRK, PFE, PFE, PFE, PFE, PFE, NVS, NVS, NVS, NVS, NVS, PPHM, PPHM, PPHM, PPHM, PPHMAmerican Association of Cancer Research to hold annual meeting
2014 Annual Meeting 2014 is being held in San Diego, California on April 5-9.
News For TLOG;NVS;PFE;MRK;AZN;TROV;SNSS;FPRX;TSRO;NLNK;FMI;AG;PPHM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 13, 2015
17:19 EDTPPHMPeregrine to highlight Bavituximab at ASCO annual meeting
Peregrine Pharmaceuticals, a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development, announced the presentation of three posters at the 2015 American Society of Clinical Oncology, ASCO, Annual Meeting, to be held May 29-June 2 in Chicago, Illinois.
16:21 EDTFPRXFive Prime files to sell $200M of common stock
Subscribe for More Information
16:16 EDTFPRXFive Prime sees FY15 cash at year end $165M-$170M
16:15 EDTFPRXFive Prime reports Q1 EPS (44c), consensus (49c)
Reports Q1 revenue $4.3M, consensus $4.93M.
13:43 EDTPFEHospira shareholders approve merger with Pfizer
Hospira (HSP) announced that Hospira shareholders voted in favor of the proposal to adopt the merger agreement with Pfizer (PFE) at a special meeting of stockholders held May 13 in Denver, Colorado. On February 5, Hospira and Pfizer announced they had entered into a merger agreement under which Pfizer will acquire Hospira for $90 per share in cash for a total enterprise value of approximately $17B. The merger is subject to customary closing conditions, one of which was approval of the merger by Hospira's shareholders. Additional closing conditions to be met include obtaining regulatory approvals in several jurisdictions. Hospira and Pfizer continue to expect the merger to close in the second half of 2015.
13:12 EDTMRKSen. Sanders urges VA to break patents on Gilead hepatitis C drugs
Subscribe for More Information
11:08 EDTNLNKOptions with decreasing implied volatility
Subscribe for More Information
07:31 EDTPFEHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
07:28 EDTFMIFoundation Medicine price target lowered to $48-52 from $60-65 at Wells Fargo
Subscribe for More Information
07:06 EDTFMIFoundation Medicine announces new data on FoundationOne assay
Subscribe for More Information
May 12, 2015
13:13 EDTMRKExpert says Norway biosimilar case an 'outlier,' CT Financial News reports
Subscribe for More Information
12:34 EDTNLNKOn The Fly: Top stock stories at midday
Subscribe for More Information
10:40 EDTNLNKNewLink Genetics weakness a buying opportunity, says Stifel
10:16 EDTNLNKOptions with decreasing implied volatility
Options with decreasing implied volatility: NDLS WTW FUEL AOL LC NLNK ZU CYBR ARWR HZNP
09:26 EDTNVSNovartis Animal Health issued FDA warning letter over marketing materials
Subscribe for More Information
09:20 EDTNLNKOn The Fly: Pre-market Movers
Subscribe for More Information
08:20 EDTFMIFoundation Medicine weakness creates buying opportunity, says JMP Securities
Subscribe for More Information
08:04 EDTNLNKNewLink Genetics weakness not a buying opportunity, says Baird
Baird noted NewLink Genetics would continue its flagship IMPRESS trial as planned despite disclosing the FDA did not endorse management's plan to switch statistical methods midstream and the trial failed to show the required 30% OS improvement to stop early for efficacy. Baird expects the shares to open lower and would not be buyers, as they believe the chance of success of its algenpantucel-L trial has been lowered. Baird maintained its Neutral rating and $41 price target on NewLink Genetics shares.
07:52 EDTTSROLeerink to hold a tour
Subscribe for More Information
06:09 EDTMRKThreshold announces Merck receives FDA Fast Track designation for evofosfamide
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use